Similarly, good results were noted in a pilot study of the ThermiVa radiofrequency product manufactured by ThermoGen
in 23 patients who underwent three treatments 1 month apart (Int J Laser Aesthet Med.
Did you ever use or need iodine socks, Izal or Miss Muffet toilet rolls, Dettolin mouthwash, Spenby exercisers, Adaptoplast first aid dressing, Thermogen
medicated wadding, Campbell's cleansing pomade, Chick Choc Tablets, Macleans Peroxide Solid Dentifrice, Carnation Corn Caps, Pickles Foot Ointment, Zam-Buk for aching feet or Fiery Jack Rubbing Ointment?
Infernal sciatica has laid me low again, for the last fortnight I have been mainly bedridden, swathed in thermogen
& heaped about with hot water bottles: but I am to get up for luncheon today & as the capture of a 'long-chained streptococcus' has been officially established from a series of what the dentist calls 'extractions,' though it let loose a flood of poison which has been the cause of this attack, still it is hoped that the breed is being eliminated by degrees & that I may be a whole man before the grave finally claims me for its own, in place of the palsied hobbler that I have been for months past.
In addition, MediChem's ThermoGen
protein expression and biocatalysis unit was awarded two patents covering a number of its biocatalysts (United States Patents 6,218,167 and 6,218,163).
ThermoGen, Inc., a MediChem company, has been awarded a Phase I Small Business Innovation Research (SBIR) grant of $100,000 from the National Cancer Institute.
ThermoGen also received an SBIR grant earlier in the year to develop a related class of proteins; DHAP-dependent aldolases, which are carbon-carbon bond catalysts with a wide array of applications in organic synthesis, especially in the field of carbohydrate chemistry.
"The recent SBIR grants that we have received will help us broaden our technology platform," said David Demirjian, Ph.D., Vice President of Technology Strategy at MediChem and President of ThermoGen. "The grant provides the opportunity to discover new enzymes to add to our existing portfolio of biocatalysts, which enables us to better assist our clients in the process development of their drug candidates." ThermoGen was acquired by MediChem last month (see MediChem press release dated June 1, 2000) to strengthen MediChem's core drug discovery and development technologies and services for the ultimate benefit of the Company's broad-reaching pharmaceutical and biotechnology client bases.